Cargando…
T cell biomarkers come to the fore in cancer immunotherapy
A comprehensive study by van der Sluis et al.(1) demonstrates immunotherapeutic targeting of OX40 and PD-L1 results in enhanced tumor clearance, which is linked to the dynamic emergence of distinct subsets of CD8(+) T cells.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140386/ https://www.ncbi.nlm.nih.gov/pubmed/37001529 http://dx.doi.org/10.1016/j.xcrm.2023.100989 |